Pyonephrosis cost-effectiveness of therapy

Pyonephrosis Microchapters
Home
Patient Information
Overview
Pathophysiology
Causes
Epidemiology and Demographics
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pyonephrosis cost-effectiveness of therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pyonephrosis cost-effectiveness of therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pyonephrosis cost-effectiveness of therapy
CDC on Pyonephrosis cost-effectiveness of therapy
Pyonephrosis cost-effectiveness of therapy in the news
Blogs on Pyonephrosis cost-effectiveness of therapy
Directions to Hospitals Treating Pyonephrosis
Risk calculators and risk factors for Pyonephrosis cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Harsh Vardhan Chawla, M.B.B.S.[2]

Cost-effectiveness of therapy

Given the significant morbidity and rapid mortality associated with pyonephrosis, and the low cost of safe and effective antibiotics, current pharmacotherapy in combination with urgent decompression to treat pyonephrosis is relatively cost-effective.